[1]
2025. CLINICAL AND LABORATORY ASSESSMENT OF IMMUNE DISORDERS IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS, DIAGNOSTIC SIGNIFICANCE OF ANTI-PLA2R. World Bulletin of Public Health. 52, (Nov. 2025), 28–31.